scispace - formally typeset
T

Tao Huang

Researcher at Chinese Academy of Sciences

Publications -  325
Citations -  12593

Tao Huang is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 41, co-authored 248 publications receiving 10196 citations. Previous affiliations of Tao Huang include CAS-MPG Partner Institute for Computational Biology & Shanghai Mental Health Center.

Papers
More filters
Journal ArticleDOI

Signal propagation in protein interaction network during colorectal cancer progression.

TL;DR: The gene expressions among the colorectal cancer patients in the aforementioned four stages were compared and the early and late stage biomarkers, respectively, were obtained and both kinds of biomarkers were mapped onto the protein interaction network.
Journal ArticleDOI

Tissue Expression Difference between mRNAs and lncRNAs.

TL;DR: Investigating tissue expression difference between mRNAs and lncRNAs revealed the heterogeneous expression pattern of lncRNA and mRNA and gave rise to the development of a new tool to identify the potential biological functions of such RNA subgroups.
Journal ArticleDOI

Identification of gene expression signatures across different types of neural stem cells with the Monte-Carlo feature selection method

TL;DR: The results not only demonstrate a high classification capacity and subtype‐specific gene expression patterns but also quantitatively reflect the pattern of the gene expression levels across the NSC lineage, providing insight into deciphering the molecular basis of NSC differentiation.
Journal ArticleDOI

Identification of Differentially Expressed Genes between Original Breast Cancer and Xenograft Using Machine Learning Algorithms

TL;DR: This study proposes a novel computational method by incorporating several machine learning algorithms, including Monte Carlo feature selection, random forest, and rough set-based rule learning, to identify genes with significant expression differences between patient-derived tumor xenograft (PDX) and original human tumors.
Journal ArticleDOI

Hepatitis C Virus Network Based Classification of Hepatocellular Cirrhosis and Carcinoma

TL;DR: It was observed that the identification accuracy was higher with the tissue samples defined by extracting the features from the second biomarker pool than that with the samples defined based on the first biomarker Pool, indicating that the novel approach holds a quite promising potential in helping find effective biomarkers for diagnosing the liver cirrhosis disease and the hepatocellular carcinoma disease.